Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 May;38(5):e364-e365.
doi: 10.1111/jdv.19692. Epub 2023 Dec 11.

Tocilizumab for refractory post-COVID-19 pansclerotic morphea

Affiliations
Case Reports

Tocilizumab for refractory post-COVID-19 pansclerotic morphea

Neerja Saraswat et al. J Eur Acad Dermatol Venereol. 2024 May.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. da Silva SJR, do Nascimento JCF, Germano Mendes RP, Guarines KM, Targino Alves da Silva C, da Silva PG, et al. Two years into the COVID‐19 pandemic: lessons learned. ACS Infect Dis. 2022;8(9):1758–1814.
    1. Lotfi Z, Haghighi A, Akbarzadehpasha A, Mozafarpoor S, Goodarzi A. Pansclerotic morphea following COVID‐19: a case report and review of literature on rheumatologic and non‐rheumatologic dermatologic immune‐mediated disorders induced by SARS‐CoV‐2. Front Med (Lausanne). 2021;8:728411.
    1. Voermans NC, Pillen S, de Jong EM, Creemers MC, Lammens M, van Alfen N. Morphea profunda presenting as a neuromuscular mimic. J Clin Neuromuscul Dis. 2008;9(4):407–414.
    1. Moreno‐Ajona D, Moreno‐Artero E, García de Eulate MR, Irimia P, España A. Facial solitary morphea profunda presenting with painful trigeminal neuropathy: a case report. Cephalalgia. 2019;39(4):564–568.
    1. Martini G, Campus S, Raffeiner B, Boscarol G, Meneghel A, Zulian F. Tocilizumab in two children with pansclerotic morphea: a hopeful therapy for refractory cases? Clin Exp Rheumatol. 2017;35 Suppl 106(4):211–213.

Substances

LinkOut - more resources